[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346056-105":59,"doc-detail-346056-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","real-world-data-on-characteristics-and-management-of-patients-with-actinic-keratosis-a-cancer-center-experience","Real-World Data on Characteristics and Management of Patients with Actinic Keratosis - A Cancer Center Experience","","Actinic keratosis is an intraepithelial lesion with potential progression to squamous cell carcinoma, requiring treatment. This retrospective study analyzed long-term real-world data from a specialized hospital in Milan to assess links among patient and lesion characteristics, treatment choice, and clinical outcomes. Among 369 patients, common features included facial localization and multiple contiguous lesions, with field-directed therapies in most cases. Follow-up regularity and incomplete response were associated with factors such as education level, skin cancer history, immunosuppression, and lesion distribution.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/real-world-data-on-characteristics-and-management-of-patients-with-actinic-keratosis-a-cancer-center-experience/346056/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/real-world-data-on-characteristics-and-management-of-patients-with-actinic-keratosis-a-cancer-center-experience/346056.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study goal regarding actinic keratosis patients?","Question",{"text":113,"@type":114},"To investigate correlations between patient and lesion characteristics, treatment option choice, and related clinical outcomes using long-term real-world data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients managed and what were the common treatment patterns?",{"text":118,"@type":114},"Field-directed therapies were prescribed in 84% of cases, and 45.5% of patients received multiple treatments, with 32% achieving complete clearance among field-directed therapy recipients.",{"name":120,"@type":111,"acceptedAnswer":121},"Which factors were associated with incomplete clinical response?",{"text":122,"@type":114},"Immunosuppression and multiple contiguous lesions were significantly associated with incomplete clinical response in multivariable analysis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346056,1790518069,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Article  \nReal-World Data on Characteristics and Management of Patients with Actinic Keratosis: A Cancer Center Experience †  \nFlavia Silvestri 1, *, Francesca Pepe 1, Sara Gandini 2, Aurora Gaeta 2,3, Paola Queirolo 4 and Giulio Tosti 1  \nAcademic Editor: KonstantinosDimas  \nReceived: 13 July 2026  \nRevised: 3 August 2026  \nAccepted: 11 August 2026  \nPublished: 12 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Dermato-Oncology Unit, European Institute of Oncology, IRCCS, 20141 Milan, Italy;  \n[francesca.pepe@ieo.it](francesca.pepe@ieo.it) (F.P.); [giulio.tosti@ieo.it](giulio.tosti@ieo.it) (G.T.)  \n2 Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, 20139 Milan, Italy; [sara.gandini@ieo.it](sara.gandini@ieo.it) (S.G.); [aurora.gaeta@ieo.it](aurora.gaeta@ieo.it) (A.G.)  \n3 Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy  \n4 Division of Medical Oncology for Melanoma, Sarcoma and Rare Tumors, European Institute of Oncology, IRCCS, 20141 Milan, Italy; [paolinaque@gmail.com](paolinaque@gmail.com)  \n* [Correspondence: flavia.silvestri@ieo.it](Correspondence: flavia.silvestri@ieo.it)  \n† This article is a revised and expanded version of a paper entitled Real-world data on characteristics and management of patients with actinic keratosis: a cancer center experience, which was presented at European Academy of Dermatology and Venereology Congress, Paris, 17–20 September 2025 .  \nAbstract  \nBackground/Objectives: Actinic keratosis is an intraepithelial lesion that may progress into squamous cell carcinoma; therefore, all lesions should be treated. The study aimed to investigate the potential correlations between patient and lesion characteristics, treatment option choice, and clinical outcomes, analyzing long-term real-world data. Methods: A retrospective study was conducted in a specialized hospital in Milan. Data on patients with actinic keratoses were collected from January 2018 to July 2024 . Results: A total of 369 patients were included, with normal weight (58%), higher educational level (83%), personal skin cancer history (51%), childhood sunburns (68%), and face localization (70%), with multiple contiguous distribution (54%) of lesions. In total, 45.5% received multiple treatments. Field-directed therapies were prescribed in 84% of cases (32% of complete clearance) . A total of 43% were lost to follow-up. Higher educational level, personal and familiar skin cancer history, previous atypical naevus excision, higher naevus count, and multiple treatments (p \u003C 0.05) were associated with regularity in visit attendance. In multivariable analysis, immunosuppression (OR = 5.01 [0.97, 29.5], p = 0.056) and multiple contiguous lesions (OR = 4.62 [1.75, 14.7], p = 0.004) were found to be significantly associated with incomplete clinical response. Conclusions: Real-world data on patients with actinic keratoses may help identify more personalized management strategies that influence treatment outcomes and adherence to follow-up.  \nKeywords: real-world data; dermato-oncology; actinic keratosis  \n1. Introduction  \nActinic keratosis (AK) is considered one of the most common dermatologic conditions diagnosed in adult patients, accounting for at least 10% of all dermatological visits [1,2] .  \nA recent meta-analysis reported a global prevalence of 14% and an estimated incidence rate of 1.9 per 1000 person-year for AKs [3] . In Italy, a high prevalence of AK in dermatology outpatients has been reported, involving around 27% of the population ≥ 30 [4] .  \nThe major risk factors associated with AKs are cumulative ultraviolet radiation exposure, older age, Fitzpatrick phototype I-II, some genetic disorders, and immunosuppression [4–8] .  \nFurthermore, the associ","cbCaiiGwuGAZJl9m","https://ap.wps.com/l/cbCaiiGwuGAZJl9m","pdf",383906,"English","# Abstract\n# Introduction\n## Actinic keratosis background and epidemiology\n## Risk factors and clinical definition\n## Treatment options and rationale for real-world evidence\n# Methods and Results\n## Study design and patient characteristics\n## Treatment patterns\n## Follow-up outcomes and predictors\n# Conclusions","[{\"question\":\"What was the study goal regarding actinic keratosis patients?\",\"answer\":\"To investigate correlations between patient and lesion characteristics, treatment option choice, and related clinical outcomes using long-term real-world data.\"},{\"question\":\"How were patients managed and what were the common treatment patterns?\",\"answer\":\"Field-directed therapies were prescribed in 84% of cases, and 45.5% of patients received multiple treatments, with 32% achieving complete clearance among field-directed therapy recipients.\"},{\"question\":\"Which factors were associated with incomplete clinical response?\",\"answer\":\"Immunosuppression and multiple contiguous lesions were significantly associated with incomplete clinical response in multivariable analysis.\"}]","Real-World Data on Characteristics and Management of Patients with Actinic Keratosis - A Cancer Center Experience | PDF",1790059888,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ac96d8ca8f53afb97f10052252f34f2.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d32f1721dc8c210e2d7ed65e0a54eed.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/369468c60a9c204bae79a314566b6ec8.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3fcedc45f2f61b1a9c550d8b9a6cce8.webp",980,1385]